Physician profile
Peter Birnstein
NPI 1255365508
$1,933.23
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $170 · 2021: $828 · 2022: $297 · 2023: $72.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $828.65 | 2019-2023 | Botox |
| Amgen INC. | $430.33 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $64.81 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $59.46 | 2021-2022 | |
| Pfizer INC. | $43.89 | 2021 | |
| Allergan, INC. | $41.48 | 2019 | |
| Alexion Pharmaceuticals, INC. | $38.73 | 2019-2021 | |
| Lilly USA, LLC | $34.27 | 2021 | |
| Akcea Therapeutics, INC. | $32.89 | 2019 | |
| Collegium Pharmaceutical, INC. | $31.49 | 2019 | |
| Supernus Pharmaceuticals, INC. | $29.53 | 2021 | |
| Almatica Pharma LLC | $28.40 | 2021 | |
| Edwards Lifesciences Corporation | $25.54 | 2021 | |
| Mallinckrodt Hospital Products INC. | $24.65 | 2021 | |
| Merz North America, INC. | $23.11 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $22.80 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $22.00 | 2019 | |
| Boston Scientific Corporation | $21.83 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.39 | 2022 | |
| Jazz Pharmaceuticals INC. | $19.57 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.24 | 2021 | |
| Lundbeck LLC | $18.56 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.80 | 2019 | |
| Vertiflex, INC. | $17.76 | 2019 | |
| Genentech USA, INC. | $15.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Birnstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.